Furthermore, peptide phosphorylation intensities between IKZF1 deleted and wild type Ph− BCP-ALL patients were very comparable as shown by the phosphorylation intensities of the thirty-eight differentially phosphorylated peptides and by the list of top 100 most highly phosphorylated peptides. This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.